碘征作为原发性脑出血患者血肿扩大和不良结局的新型预测标志物
该前瞻性研究纳入2014至2017年91例自发性脑出血发病6小时内行光谱CT血管造影的患者,比较碘征与点征预测早期血肿扩大和不良功能结局的价值。碘征独立预测血肿扩大(OR 53.67,95%CI 11.88-242.42,P<0.001),且敏感度、阴性预测值和准确率均高于点征,并与不良功能结局显著相关。
要点
- 碘征独立预测血肿扩大,OR 53.67(95%CI 11.88-242.42,P<0.001)。
- 碘征检测血肿扩大的敏感度91.5% vs 点征63.8%,准确率85.7% vs 75.8%。
- 碘征与不良功能结局显著相关(χ2=29.97,P<0.001),点征则否。
核心结论
- 碘征是预测血肿扩大和不良功能结局的可靠且敏感的标志物。
研究设计与样本
- 前瞻性研究纳入2014至2017年91例自发性脑出血发病6小时内行光谱CT血管造影的患者。
主要发现
- 点征阳性者占38.5%(35/91),碘征阳性者占57.1%(52/91)。
- 多因素分析显示碘征独立预测血肿扩大(OR 53.67,95%CI 11.88-242.42,P<0.001)。
- 碘征检测血肿扩大的敏感度91.5% vs 点征63.8%,阴性预测值89.7% vs 69.9%,准确率85.7% vs 75.8%。
- 碘征与不良功能结局(严重残疾和植物状态)显著相关(χ2=29.97,P<0.001),点征则无显著相关。
关键数值与推荐
- 碘征阳性定义为光谱CT图像上血肿内微小强化灶且灶内碘浓度>7.82(100 µg/mL)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- The aim of the study was to investigate the utility of iodine contrast agent leakage (the iodine sign) analyzed by Gemstone spectral imaging in early hematoma formation compared with that of the spot sign for predicting early hematoma expansion (HE) and poor functional outcomes. Methods- From 2014 to 2017, 91 patients with spontaneous intracerebral hemorrhage who underwent spectral computed tomography angiography within 6 hours of spontaneous intracerebral hemorrhage onset were prospectively included in our study. We defined a positive iodine sign as tiny enhancing foci within the hematoma on Gemstone spectral imaging and an iodine concentration inside the foci of >7.82 (100 µg/mL). Univariate and multivariate logistical regression analyses were performed to assess risk factors for HE, and the predictive value of HE was analyzed. Results- Positive spot and iodine signs were present in 38.5% (35/91) and 57.1% (52/91) of the patients, respectively. Using multivariate analysis, the iodine sign independently predicted HE (odds ratio, 53.67; 95% CI, 11.88-242.42; P<0.001) and had a higher sensitivity (91.5% versus 63.8%), negative predictive value (89.7% versus 69.9%), and accuracy (85.7% versus 75.8%) for detecting HE than the spot sign. The iodine sign, but not the spot sign, was significantly related to poor functional outcomes (severely disabled and vegetative state) in all patients (χ2=29.97; P<0.001). Conclusions- The iodine sign is a reliable and sensitive marker for predicting HE and poor functional outcomes. Clinical Trial Registration- URL: https://www.clinicaltrials.gov . Unique identifier: NCT02625948.
引用
- Fu F, Sun S, Liu L, et al. Iodine Sign as a Novel Predictor of Hematoma Expansion and Poor Outcomes in Primary Intracerebral Hemorrhage Patients. Stroke. 2018. PMID: 30354984. doi:10.1161/STROKEAHA.118.022017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。